Hedge Fund Alert: Bridgewater Associates Owns These Healthcare Stocks the Most in Q3

Following is information regarding Bridgewater Associates’ top holdings in the Healthcare sector for the week ending September 30th, 2011.

  • Community Health Systems, Inc. (NYSE:CYH): On 6/30/11 Bridgewater Associates reported holding 958,497 shares with a market value of $24,614,203. This comprised 0.35% of the total portfolio. On 9/30/11, Bridgewater Associates held 1,503,661 shares with a market value of $25,020,918. This comprised 0.37% of the total portfolio. The net change in shares for this position over the two quarters is 545,164. About the company: Community Health Systems Inc. owns, leases, and operates hospitals in multiple states. The Hospitals services include emergency room services, general surgery, critical care, internal medicine, obstetrics and diagnostic services. Community Health also owns interests in physicians, physician practices, imaging centers, home health agencies and ambulatory surgery centers.
  • Endo Pharmaceutical Holdings, Inc. (NASDAQ:ENDP): On 6/30/11 Bridgewater Associates reported holding 240,439 shares with a market value of $9,658,434. This comprised 0.14% of the total portfolio. On 9/30/11, Bridgewater Associates held 850,319 shares with a market value of $23,800,429. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is 609,880. About the company: Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo’s products include Percocet, Percodan, and Lidoderm.
  • Pfizer, Inc. (NYSE:PFE): On 6/30/11 Bridgewater Associates reported holding 692,700 shares with a market value of $14,269,620. This comprised 0.20% of the total portfolio. On 9/30/11, Bridgewater Associates held 1,282,500 shares with a market value of $22,674,600. This comprised 0.34% of the total portfolio. The net change in shares for this position over the two quarters is 589,800. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Johnson & Johnson (NYSE:JNJ): On 6/30/11 Bridgewater Associates reported holding 300,000 shares with a market value of $19,955,999. This comprised 0.28% of the total portfolio. On 9/30/11, Bridgewater Associates held 288,500 shares with a market value of $18,374,565. This comprised 0.27% of the total portfolio. The net change in shares for this position over the two quarters is -11,500. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Dentsply International, Inc. (NASDAQ:XRAY): On 6/30/11 Bridgewater Associates reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 9/30/11, Bridgewater Associates held 550,695 shares with a market value of $16,900,830. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is 550,695. About the company: DENTSPLY International Inc. manufactures and distributes dental supplies on a worldwide basis. The Company’s products include dental prosthetics, endodontic instruments, dental sealants, ultrasonic scalers, dental x-ray equipment, and intraoral cameras. DENTSPLY also provides impression materials, orthodontic appliances, and dental operatory software systems, and other dental products.
  • Merck & Co., Inc. (NYSE:MRK): On 6/30/11 Bridgewater Associates reported holding 492,300 shares with a market value of $17,373,267. This comprised 0.25% of the total portfolio. On 9/30/11, Bridgewater Associates held 458,941 shares with a market value of $15,007,371. This comprised 0.22% of the total portfolio. The net change in shares for this position over the two quarters is -33,359. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Thermo Fisher Scientific, Inc. (NYSE:TMO): On 6/30/11 Bridgewater Associates reported holding 199,942 shares with a market value of $12,874,265. This comprised 0.18% of the total portfolio. On 9/30/11, Bridgewater Associates held 276,567 shares with a market value of $14,005,353. This comprised 0.21% of the total portfolio. The net change in shares for this position over the two quarters is 76,625. About the company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Mylan, Inc. (NASDAQ:MYL): On 6/30/11 Bridgewater Associates reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 9/30/11, Bridgewater Associates held 668,912 shares with a market value of $11,364,815. This comprised 0.17% of the total portfolio. The net change in shares for this position over the two quarters is 668,912. About the company: Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.
  • Varian Medical Systems, Inc. (NYSE:VAR): On 6/30/11 Bridgewater Associates reported holding 4,459 shares with a market value of $312,219. This comprised 0.00% of the total portfolio. On 9/30/11, Bridgewater Associates held 191,400 shares with a market value of $9,983,424. This comprised 0.15% of the total portfolio. The net change in shares for this position over the two quarters is 186,941. About the company: Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy. The Company also supplies products that include x-ray tubes, linear accelerators, digital image detectors, image processing software and image detection products.

(Note: Data regarding Bridgewater Associates’ stock holdings are sourced from whalewisdom.com.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>